![Richard Scalzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Scalzo
Nessuna posizione attualmente
Patrimonio netto: 904 151 $ in data 31/07/2026
Profilo
Richard William Scalzo is Chief Financial Officer at Crescent Biopharma, Inc. since 2025.
Formerly, Mr. Scalzo was Controller at Dyne Therapeutics, Inc. from 2019 to 2020, Chief Accounting Officer at Kaleido Biosciences, Inc. in 2019, Controller at X4 Pharmaceuticals, Inc. from 2016 to 2018, Controller at Astellas Institute for Regenerative Medicine in 2014.
Education includes an undergraduate degree from Boston College conferred in 2008 and an MBA from the University of Massachusetts conferred in 2016.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2026 | 24.243 ( 0,01% ) | 610 439 $ | 31/07/2026 | |
0,05% | 22/06/2026 | 20.298 ( 0,05% ) | 293 712 $ | 31/07/2026 |
Posizioni attive di Richard Scalzo
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Richard Scalzo
| Società | Posizione | Fine |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 29/11/2019 |
| X4 PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/08/2018 |
| OCATA THERAPEUTICS INC | Comptroller/Controller/Auditor | 01/09/2014 |
| DYNE THERAPEUTICS, INC. | Direttore Finanziario/CFO | - |
Formazione di Richard Scalzo
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
91
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Dyne Therapeutics, Inc.
 Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
